Bone marrow cells participate in tumor vessel formation that supports the growth of Ewing's sarcoma in the lung

Angiogenesis

Volumn 14, Issue 2, 2011, Pages 125-133

  Zhou, Zhichao ^a   Stewart, Keri Schadler ^a   Yu, Ling ^a   Kleinerman, Eugenie S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bone marrow cells; Ewing's sarcoma; Metastasis; Neovascularization; Vasculogenesis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; DESMIN; INTERLEUKIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CANCER GROWTH; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; DNA POLYMORPHISM; EWING SARCOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG METASTASIS; LUNG NODULE; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TUMOR ENGRAFTMENT; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; H-2 ANTIGENS; HUMANS; INTERLEUKIN-1BETA; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; POLYMORPHISM, GENETIC; REPRODUCIBILITY OF RESULTS; SARCOMA, EWING'S; SPECIES SPECIFICITY;

MUS;

EID: 79959933875     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-010-9196-7     Document Type: Article

References (24)

1. Weigelt B, Peterse JL, van 't Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5:591-602 (Pubitemid 41081385)
2. Fidler IJ (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3:453-458 (Pubitemid 37328849)
3. Paulussen M, Ahrens S, Craft AW, Dunst J, Frohlich B, Jabar S, Rube C, Winkelmann W, Wissing S, Zoubek A et al (1998) Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients. J Clin Oncol 16:3044-3052 (Pubitemid 28417425)
4. Riggi N, Stamenkovic I (2007) The biology of Ewing sarcoma. Cancer Lett 254:1-10 (Pubitemid 47058800)
5. Barker LM, Pendergrass TW, Sanders JE, Hawkins DS (2005) Survival after recurrence of Ewing's sarcoma family of tumors. J Clin Oncol 23:4354-4362 (Pubitemid 46207009)
6. Terek RM, Brien EW, Marcove RC, Meyers PA, Lane JM, Healey JH (1996) Treatment of femoral Ewing's sarcoma. Cancer 78:70-78 (Pubitemid 26189907)
7. Miser JS, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA et al (2004) Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination if-osfamide and etoposide - a Children's Cancer Group and Pediatric Oncology Group study. J Clin Oncol 22:2873-2876 (Pubitemid 41079906)
8. Bolontrade MF, Zhou RR, Kleinerman ES (2002) Vasculogenesis plays a role in the growth of Ewing's sarcoma in vivo. Clin Cancer Res 8:3622-3627 (Pubitemid 35340741)
9. Reddy K, Cao Y, Zhou Z, Yu L, Jia SF, Kleinerman ES (2008) VEGF165 expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing's sarcoma vasculature. Angiogenesis 11:257-267
10. Reddy K, Zhou Z, Schadler K, Jia SF, Kleinerman ES (2008) Bone marrow subsets differentiate into endothelial cells and pericytes contributing to Ewing's tumor vessels. Mol Cancer Res 6:929-936
11. Lee TH, Bolontrade MF, Worth LL, Guan H, Ellis LM, Kleinerman ES (2006) Production of VEGF165 by Ewing's sarcoma cells induces vasculogenesis and the incorporation of CD34+ stem cells into the expanding tumor vasculature. Int J Cancer 119:839-846 (Pubitemid 44051447)
12. Zhou Z, Reddy K, Guan H, Kleinerman ES (2007) VEGF(165), but not VEGF(189), stimulates vasculogenesis and bone marrow cell migration into Ewing's sarcoma tumors in vivo. Mol Cancer Res 5:1125-1132 (Pubitemid 350137108)
13. Reddy K, Zhou Z, Jia SF, Lee TH, Morales-Arias J, Cao Y, Kleinerman ES (2008) Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor. Int J Cancer 123:831-837 (Pubitemid 352032409)
14. Guan H, Zhou Z, Wang H, Jia SF, Liu W, Kleinerman ES (2005) A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model. Clin Cancer Res 11:2662-2669 (Pubitemid 40569467)
15. Yu L, Su B, Hollomon M, Deng Y, Facchinetti V, Kleinerman ES (2010) Vasculogenesis driven by bone marrow-derived cells is essential for growth of Ewing's sarcomas. Cancer Res 70: 1334-1343
16. Jia SF, Worth LL, Kleinerman ES (1999) A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies. Clin Exp Metastasis 17:501-506 (Pubitemid 30182744)
17. Jacob CO, Mykytyn K, Tashman N (1993) DNA polymorphism in cytokine genes based on length variation in simple-sequence tandem repeats. Immunogenetics 38:251-257 (Pubitemid 23241034)
18. Gao D, Nolan D, McDonnell K, Vahdat L, Benezra R, Altorki N, Mittal V (2009) Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim Biophys Acta 1796:33-40
19. Taylor M, Rossler J, Geoerger B, Laplanche A, Hartmann O, Vassal G, Farace F (2009) High levels of circulating VEG-FR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies. Clin Cancer Res 15:4561-4571
20. Zhou Z, Bolontrade MF, Reddy K, Duan X, Guan H, Yu L, Hicklin DJ, Kleinerman ES (2007) Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy. Clin Cancer Res 13:4867-4873 (Pubitemid 47294794)
21. Aiuti A, Webb IJ, Bleul C, Springer T, Gulierrez-Ramos JC (1997) The chemmokine SDF-1 ia a chemoattractan for human CD34+ hemotopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 185:111-120 (Pubitemid 27039446)
22. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegue E, Song H, VandenBerg S, Johnson RS, Werb Z, Bergers G (2008) HIF1a induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13:206-220 (Pubitemid 351318372)
23. Erier JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, Le Q, Giaccia AJ (2009) Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15:35-44
24. Gao D, Mittal V (2009) The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression. Trends Mol Med 15:333-343